Disease Areas

GlaxoSmithKline Eyes Regulatory Filing After Positive Phase III Jemperli Data in Endometrial Cancer

Novartis to Seek Pluvicto Approval in Another Advanced PSMA-Positive Prostate Cancer Setting

FDA Approves Rigel Pharmaceuticals' Rezlidhia for IDH1-Mutant AML

Sofie Biosciences to Begin Trial of Fluorine-Labeled PET Diagnostic Imaging Agent for GI Cancers

Study Unearths Features Found in Long-Term Survivors of Advanced Ovarian Cancer

Carrick Therapeutics Receives $35M Investment From Pfizer; Raises $25M in Series C Funding Round

Addario Lung Cancer Medical Institute Begins Study Exploring KRAS Inhibitor Resistance

Erasca Inks Deal With Pierre Fabre on ERAS-007, Braftovi Combo Study in Colorectal Cancer

Personalis, UCSF to Study ctDNA Utility in Colorectal Cancer Treatment Response Monitoring

Alaunos Therapeutics Expecting $15.7M in Common Stock Offering

Genentech to Withdraw First-Line Tecentriq Bladder Cancer Indication

Tyra Biosciences Begins Phase I/II Trial of TYRA-300 in FGFR3-Mutant Bladder, Urinary Tract Cancer

Studies Assess Tumor Aneuploidy to Guide Immunotherapy Treatment

Exscientia Receives Regulatory Nod to Start AI-Aided Phase I/II Trial

NICE Recommends BMS's Opdivo Plus Chemo for HER2-Negative, PD-L1-Positive Gastric Cancer

OncoDNA, Eli Lilly Partner on Thyroid Cancer Biomarker Testing

Halo Diagnostics, Ikonopedia Partner to Provide Genetic Testing for Breast Cancer

Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test